Masaharu Akao Selected Research

Heparin (Liquaemin)

1/2023	Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure.
2/2022	Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaharu Akao Research Topics

Disease

82	Atrial Fibrillation 04/2024 - 10/2008
62	Hemorrhage 05/2024 - 07/2016
55	Stroke (Strokes) 01/2024 - 01/2011
22	Heart Failure 05/2024 - 03/2004
22	Embolism (Embolus) 01/2024 - 01/2015
20	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 08/2018
16	Myocardial Infarction 05/2024 - 03/2003
16	Ischemic Stroke 05/2024 - 01/2015
13	Thrombosis (Thrombus) 05/2024 - 02/2009
11	Neoplasms (Cancer) 05/2023 - 03/2004
10	Venous Thromboembolism 11/2022 - 07/2016
6	Body Weight (Weight, Body) 01/2024 - 11/2020
6	Thromboembolism 01/2023 - 01/2019
5	Chronic Renal Insufficiency 01/2022 - 08/2014
4	Acute Coronary Syndrome 05/2024 - 01/2020
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 01/2022
4	ST Elevation Myocardial Infarction 01/2023 - 10/2014
4	Unstable Angina 12/2022 - 10/2014
4	Cardiac Arrhythmias (Arrythmia) 12/2022 - 01/2018
4	Coronary Disease (Coronary Heart Disease) 09/2022 - 01/2019
3	Frailty 05/2024 - 01/2022
3	Diabetes Mellitus 02/2024 - 12/2017
3	Hypertrophy 09/2022 - 02/2006
3	Hypertension (High Blood Pressure) 01/2021 - 12/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 10/2010
3	Atherosclerosis 11/2016 - 01/2011
3	Reperfusion Injury 01/2014 - 10/2006
2	Hypotension (Low Blood Pressure) 04/2024 - 01/2023
2	COVID-19 04/2024 - 01/2023
2	Thrombocytopenia (Thrombopenia) 10/2023 - 01/2022
2	Cardiomyopathies (Cardiomyopathy) 01/2023 - 10/2009
2	Infections 01/2023 - 04/2014
2	Anemia 06/2022 - 11/2020
2	Thrombophilia 01/2022 - 04/2019
2	Death (Near-Death Experience) 01/2022 - 12/2018
2	Tachycardia (Tachyarrhythmias) 08/2021 - 01/2015
2	Obesity 11/2016 - 01/2011
2	Weight Gain 11/2016 - 11/2015
2	Infarction (Infarctions) 10/2014 - 01/2014
2	Ischemia 01/2014 - 03/2003
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014 - 11/2003
2	Long QT Syndrome 10/2010 - 10/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2009 - 10/2003
2	Brugada Syndrome 10/2008 - 12/2005
1	Tobacco Use Disorder (Nicotine Dependence) 01/2024

Drug/Important Bio-Agent (IBA)

57	AnticoagulantsIBA 02/2024 - 04/2013
21	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 04/2013
18	RivaroxabanIBA 04/2024 - 08/2017
12	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2024 - 08/2018
12	CreatinineIBA 11/2023 - 10/2014
12	apixabanIBA 06/2022 - 12/2016
9	edoxabanIBA 01/2024 - 12/2017
6	Vitamin K FDA Link 11/2022 - 01/2016
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 02/2009
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 01/2020
4	Clopidogrel (Plavix)FDA Link 10/2023 - 08/2009
4	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2022 - 01/2018
4	vinyltriethoxysilane (VTES)IBA 01/2020 - 01/2019
4	oxidized low density lipoproteinIBA 11/2016 - 01/2011
3	ChromiumIBA 05/2024 - 01/2020
3	Everolimus FDA Link 05/2024 - 01/2020
3	CobaltIBA 05/2024 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 01/2020
3	fibrin fragment D (D-dimer)IBA 08/2023 - 05/2020
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 12/2020
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2011
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2011
3	Vascular Endothelial Growth Factor CIBA 01/2020 - 01/2011
2	Indicators and Reagents (Reagents)IBA 05/2024 - 01/2019
2	Oxygen (Dioxygen)IBA 04/2024 - 01/2016
2	Carvedilol (Coreg)FDA LinkGeneric 01/2023 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 02/2022
2	pro-brain natriuretic peptide (1-76)IBA 11/2021 - 01/2021
2	Anti-Arrhythmia AgentsIBA 12/2018 - 10/2009
2	CholesterolIBA 11/2018 - 01/2011
2	Syntex adjuvant formulationIBA 10/2018 - 12/2017
2	Lipoproteins (Lipoprotein)IBA 11/2016 - 11/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2015 - 01/2012
2	serofendic acidIBA 01/2014 - 01/2007
2	Ion Channels (Ion Channel)IBA 10/2010 - 10/2009
2	Adenosine Triphosphate (ATP)IBA 10/2009 - 11/2003
2	Purinergic P2Y Receptor AntagonistsIBA 08/2009 - 02/2009
1	Prasugrel Hydrochloride FDA Link 05/2024
1	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 05/2024
1	Angiotensin Receptor AntagonistsIBA 04/2024
1	Carbon MonoxideIBA 01/2024
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2023

Therapy/Procedure

60	Therapeutics 05/2024 - 10/2006
13	Percutaneous Coronary Intervention 02/2023 - 08/2009
9	Stents 05/2024 - 02/2009
7	Catheter Ablation 11/2023 - 12/2018
3	Polypharmacy 01/2024 - 12/2022
3	Drug Therapy (Chemotherapy) 12/2022 - 10/2019
2	Palliative Care (Palliative Therapy) 05/2024 - 01/2022
2	Secondary Prevention 01/2020 - 04/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 08/2018
2	Intravenous Administration 01/2014 - 12/2005
1	Mechanical Ventilators (Ventilator) 04/2024
1	Extracorporeal Membrane Oxygenation 04/2024